Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone
Sign Up to like & getrecommendations! Published in 2022 at "IDCases"
DOI: 10.1016/j.idcr.2022.e01460
Abstract: Tafenoquine is a highly effective treatment for Babesia microti infections in animal models. An immunocompromised patient infected by a strain of B. microti that was at least partially resistant to both azithromycin and atovaquone was… read more here.
Keywords: use tafenoquine; treat patient; azithromycin atovaquone; tafenoquine treat ... See more keywords